India Ramps Up Fight Against Cervical Cancer with Mass Vaccination and Screening

India is making a significant push to wipe out cervical cancer, with Union Health Minister JP Nadda recently reaffirming the country's strong commitment to this goal on the global stage. This renewed resolve comes as India expands its nationwide Human Papillomavirus (HPV) vaccination campaign, launched earlier this year, alongside extensive screening and early treatment efforts across the country. The initiative is crucial as India currently accounts for about a quarter of the world's cervical cancer deaths, making this a top public health priority. The comprehensive strategy includes a major HPV vaccination drive, kicked off by Prime Minister Narendra Modi on February 28, 2026, aiming to vaccinate approximately 12 million adolescent girls aged 14 years with a free, single-dose Gardasil Quadrivalent vaccine. This is happening at government health centers, with over 5.21 million girls already vaccinated by mid-July 2026. Complementing this, more than 86 million women aged 30-65 have undergone cervical cancer screening using Visual Inspection with Acetic Acid (VIA) at facilities like Ayushman Arogya Mandirs. A recent breakthrough in June 2026 saw India validating its first indigenous HPV test, set to make detection more affordable and accessible, especially in rural areas. Looking ahead, India's multi-pronged approach aligns with the World Health Organization ambitious 90-70-90 targets for cervical cancer elimination by 2030, which means vaccinating 90% of girls, screening 70% of women, and treating 90% of those diagnosed. While past concerns around vaccine hesitancy and earlier demonstration projects have been a challenge, transparent communication and continued monitoring of Adverse Events Following Immunization (AEFI) are key to building public trust. The success of this sustained, widespread effort will be vital in safeguarding the health and dignity of Indian women for generations to come.